Framework Ventures IV L.P. - Oct 16, 2025 SCHEDULE 13D/A Report for NovaBay Pharmaceuticals, Inc. Common Stock, $0.01 par value (NBY)

Filing Manager
Framework Ventures IV L.P.
Reporting Manager
Framework Ventures IV L.P.
Security
NovaBay Pharmaceuticals, Inc. Common Stock, $0.01 par value
Symbol
NBY
Shares outstanding
126M shares
Disclosed Ownership
56.8M shares
Ownership
45.1%
Form type
SCHEDULE 13D/A
Date filed
10/20/2025, 09:42 PM
Date of event
Oct 16, 2025
Previous filing
Oct 15, 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Framework Ventures IV L.P. 45.1% 56.8M 0 56.8M /s/ Michael Ernest Anderson Michael Ernest Anderson / Authorized Signatory 0002028474
Framework Ventures Management LLC 45.1% 56.8M 0 56.8M /s/ Michael Ernest Anderson Michael Ernest Anderson / Authorized Signatory 0002091751
Framework Ventures IV GP LLC 45.1% 56.8M 0 56.8M /s/ Michael Ernest Anderson Michael Ernest Anderson / Authorized Signatory 0002092591
Vance Spencer 45.1% 56.8M 0 56.8M /s/ Vance Spencer Vance Spencer 0002092030
Michael Ernest Anderson 45.1% 56.8M 0 56.8M /s/ Michael Ernest Anderson Michael Ernest Anderson